September 11, 2012
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs reviewed and recommended approval for five products/indications on September 6 including Novartis Pharma’s chronic obstructive pulmonary disease (COPD) treatment glycopyrronium bromide. All five products are expected to receive...read more